ADA 2026 Standards — Expanded CGM Access

Type: procedure

Status: Active policy

Developer: American Diabetes Association

Breakthrough Summary

New Recommendation 7.8a removes requirements for C-peptide levels, islet autoantibodies, or diabetes duration for CGM access. All CGM types now recognized. New ICD-10 code E11.A for T2D remission.

Mechanism of Action

Recommendation 7.8a removes requirements for C-peptide, islet autoantibodies, or diabetes duration for CGM access

Year: 2026